arrow
M

Mariusz Jaremko

king abdullah university of science & technology
H指数:50
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Isolation and structural characterisation of a novel pentacyclic saponin from Lomelosia stellata with in silico antifebrile and anti-inflammatory insights and in vivo antipyretic evaluation of the n-butanol extract

从Lomelosia stellata中分离和结构表征一种新型五环皂苷,并对其体外抗发热和抗炎作用进行计算机模拟分析以及对正丁醇提取物的体内解热效果进行评价

2026-02-010
PRE
SH3 domains selectively activate the PI3 kinase through non-conventional tertiary contacts

SH3结构域通过非常规三级接触选择性激活PI3激酶

2026-01-190
OAAI
Design, Synthesis, and Antiproliferative Efficacy of an Innovative Series of Triazino[5,6-b]indole Derivatives Targeting EGFR, CD1, Hsp90, PI3K, and ERK/AKT as Key Molecular Targets in Cancer Therapy

设计、合成及靶向EGFR、CD1、Hsp90、PI3K和ERK/AKT作为癌症治疗关键分子靶点的新型三氮唑[5,6-b]吲哚衍生物的抗增殖活性

2025-10-160
PRE
Targeted design, synthesis, molecular dynamics, ADME and in –vitro anticancer assessment of oxo-tetrahydro-pyrimidin-benzenesulfonamide hybrids as potential BRAFV600E inhibitors

靶向设计、合成、分子动力学、ADME及体外抗肿瘤评估:作为潜在BRAFv600E抑制剂的氧杂四氢嘧啶-苯磺酰胺杂化物

2025-10-080
OA
Design and synthesis of multitarget triazinoindole derivatives with potent antiproliferative activity: Targeting EGFR, SIRT1, MDM2, Hsp90, PI3K, p53, and caspase-9

多靶点三氮唑并吲哚衍生物的设计与合成:具有强抗增殖活性,靶向EGFR、SIRT1、MDM2、Hsp90、PI3K、p53和caspase-9

2025-09-050
PRE
Synthesis, Identification, and Characterization of a Novel 1,2,5-Selenadiazole Derivative as a Microtubule Targeting Agent That Overcomes Multidrug Resistance

一种新型1,2,5-硒二唑衍生物的合成、鉴定与表征:作为克服多药耐药性的微管靶向剂

2025-09-030
PRE
NSD2 inhibitors rewire chromatin to treat lung and pancreatic cancers

NSD2抑制剂通过重塑染色质来治疗肺癌和胰腺癌

Nature
IF48.5
2025-08-060
PRE